title: BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
authors.affiliation: Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UK.
authors.forename: C
authors.initials: C
authors.lastname: Lapraik
authors.forename: R
authors.initials: R
authors.lastname: Watts
authors.forename: P
authors.initials: P
authors.lastname: Bacon
authors.forename: D
authors.initials: D
authors.lastname: Carruthers
authors.forename: K
authors.initials: K
authors.lastname: Chakravarty
authors.forename: D
authors.initials: D
authors.lastname: D'Cruz
authors.forename: L
authors.initials: L
authors.lastname: Guillevin
authors.forename: L
authors.initials: L
authors.lastname: Harper
authors.forename: D
authors.initials: D
authors.lastname: Jayne
authors.forename: R
authors.initials: R
authors.lastname: Luqmani
authors.forename: J
authors.initials: J
authors.lastname: Mooney
authors.forename: D
authors.initials: D
authors.lastname: Scott
mesh_terms: D000328:Adult; D000465:Algorithms; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D012008:Recurrence; D014657:Vasculitis / Q000188:drug therapy* / Q000276:immunology